Abstract
It was shown for the first time that the endogenous cyclic dipeptide cycloprolylglycine (CPG) at concentrations of 10–7 and 10–3 M and piracetam at a concentration of 10–3 M increased the content of brainderived neurotrophic factor (BDNF) in the culture of neuronal cells in normal state and under conditions of glutamate and 6-oxydopamine neurotoxicity. This may indicate the possible involvement of BDNF in the mechanism of action of neuropeptide CPG and piracetam.
Similar content being viewed by others
References
Gudasheva, T.A., Boyko, S.S., Akparov, V.Kh., Ostrovskaya, R.U., Skoldinov, A.P., Rozantsev, G.G., Voronina, T.A., Zherdev, V.P., and Seredenin, S.B., FEBS Lett., 1996, vol. 391, pp. 149–152.
Guan, J., Mathai, S., Harris, P., Wen, J.-Y., Zhang, R., Brimble, M., and Gluckman, P., Neuropharmacology, 2007, vol. 53, no. 6, pp. 749–762.
Gudasheva, T.A., Vasilevich, N.I., Zolotov, N.N., Lezina, V.P., Rozenberg, S.G., Kravchenko, E.V., Ostrovskaya, R.U., Voronina, T.A., Rozantsev, G.G., and Skoldinov, A.P., Khim.-Farm. Zh., 1991, vol. 25, no. 6, pp. 12–16.
Gudasheva, T.A., Ostrovskaya, R.U., Trofimov, S.S., Voronina, T.A., Skoldinov, A.P., and Seredenin, S.B., Byull. Eksp. Biol. Med., 1999, vol. 116, no. 10, pp. 411–413.
Gudasheva, T.A., Konstantinopol’skii, M.A., Ostrovskaya, R.U., and Seredenin, S.B., Byull. Eksp. Biol. Med., 2001, vol. 131, no. 5, pp. 547–550.
Seredenin, S.B., Gudasheva, T.A., Boiko, S.S., Kovalev, G.I., Voronin, M.V., and Yarkova, M.A., Byull. Eksp. Biol. Med., 2002, vol. 133, no. 4, pp. 417–419.
Kolyasnikova, K.N., Gudasheva, T.A., Nazarova, G.A., Antipov, P.I., Nikolaev, S.V., Antipova, T.A., Voronina, T.A., and Seredenin, S.B., Eksp. Klin. Farmakol., 2012, vol. 75, no. 9, pp. 3–6.
Povarnina, P.Yu., Kolyasnikova, K.N., Nikolaev, S.V., Antipova, T.A., and Gudasheva, T.A., Byull. Eksp. Biol. Med., 2015, vol. 160, no. 11, pp. 600–603.
Ahmed, A.H. and Oswald, R.E.., J. Med. Chem., 2010, vol. 53, no. 5, pp. 2197–2203.
Jourdi, H., Hsu, Y.-T., Zhou, M., Qin, Q., Bi, X., and Baudry, M., J. Neurosci., 2009, vol. 29, no. 27, pp. 8688–8697.
Autry, A.E. and Monteggia, L.M., Pharmacol. Rev., 2012, vol. 64, no. 2, pp. 238–258.
Firstova, Yu.Yu., Dolotov, O.V., Kondrakhin, E.A., Dubynina, E.V., Grivennikov, I.A., and Kovalev, G.I., Eks. Klin. Farmakol., 2009, vol. 72, no. 6, pp. 6–9.
Goswami, P., Swarnkar, S., Harsoliya, M.S., Singh, S., Nath, C., and Sharma, S., J. Pharmacy Res., 2011, vol. 4, no. 6, pp. 1716–1719.
Towbin, H., Staehelin, T., and Gordon, J., Proc. Nat. Acad. Sci U. S. A., 1979, vol. 76, no. 9, pp. 4350–4354.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © T.A. Gudasheva, K.N. Koliasnikova, T.A. Antipova, S.B. Seredenin, 2016, published in Doklady Akademii Nauk, 2016, Vol. 469, No. 4, pp. 492–495.
Rights and permissions
About this article
Cite this article
Gudasheva, T.A., Koliasnikova, K.N., Antipova, T.A. et al. Neuropeptide cycloprolylglycine increases the levels of brain-derived neurotrophic factor in neuronal cells. Dokl Biochem Biophys 469, 273–276 (2016). https://doi.org/10.1134/S1607672916040104
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1607672916040104